Formosa Laboratories Inc, based in Taiwan, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is SEVELAMER CARBONATE, with a corresponding US DMF Number 23039.
Remarkably, this DMF maintains an Active status since its submission on August 13, 2009, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of May 21, 2013, and payment made on November 23, 2012, indicating their dedication to facilitating drug approvals, Categorized as Type II